[HTML][HTML] Poor time in therapeutic range control is associated with adverse clinical outcomes in patients with non-valvular atrial fibrillation: a report from the nationwide …
R Krittayaphong, T Chantrarat… - Journal of Clinical …, 2020 - mdpi.com
Background: Warfarin remains the most commonly used oral anticoagulant (OAC) in
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Poor time in therapeutic range control is associated with adverse clinical outcomes in patients with non-valvular atrial fibrillation: A report from the nationwide cool-af …
R Krittayaphong, T Chantrarat… - Journal of Clinical …, 2020 - mahidol.elsevierpure.com
Background: Warfarin remains the most commonly used oral anticoagulant (OAC) in
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide …
R Krittayaphong, T Chantrarat… - Journal of Clinical …, 2020 - vbn.aau.dk
BACKGROUND: Warfarin remains the most commonly used oral anticoagulant (OAC) in
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide …
R Krittayaphong, T Chantrarat… - Journal of Clinical …, 2020 - europepmc.org
Background Warfarin remains the most commonly used oral anticoagulant (OAC) in
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide …
R Krittayaphong, T Chantrarat… - Journal of Clinical …, 2020 - search.proquest.com
Background: Warfarin remains the most commonly used oral anticoagulant (OAC) in
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide …
R Krittayaphong, T Chantrarat… - Journal of Clinical …, 2020 - search.ebscohost.com
Background: Warfarin remains the most commonly used oral anticoagulant (OAC) in
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
[HTML][HTML] Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the …
R Krittayaphong, T Chantrarat… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
Background: Warfarin remains the most commonly used oral anticoagulant (OAC) in
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
[PDF][PDF] Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the …
R Krittayaphong, T Chantrarat, R Rojjarekampai… - J. Clin. Med, 2020 - core.ac.uk
Background: Warfarin remains the most commonly used oral anticoagulant (OAC) in
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
[PDF][PDF] Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the …
R Krittayaphong, T Chantrarat… - J. Clin …, 2020 - pdfs.semanticscholar.org
Background: Warfarin remains the most commonly used oral anticoagulant (OAC) in
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide …
R Krittayaphong, T Chantrarat… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Warfarin remains the most commonly used oral anticoagulant (OAC) in
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …
Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF) …